Long-Term Follow-Up of Patients With Chronic Lymphocytic Leukemia (CLL) Receiving Fludarabine Regimens as Initial Therapy
- 15 August 1998
- journal article
- Published by American Society of Hematology in Blood
- Vol. 92 (4) , 1165-1171
- https://doi.org/10.1182/blood.v92.4.1165
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Fludarabine in Resistant or Relapsing B-Cell Chronic Lymphocytic LeukemiaThe Spanish GroupExperienceLeukemia & Lymphoma, 1996
- Is the CHOP Regimen a Good Treatment for Advanced CLL? Results from two Randomized Clinical TrialsLeukemia & Lymphoma, 1994
- Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]Blood, 1993
- Long-term follow-up of patients with chronic lymphocytic leukemia treated with fludarabine as a single agentBlood, 1993
- Treatment of advanced chronic lymphocytic leukemia by fludarabineAnnals of Hematology, 1991
- Long-Term Results of CAP Therapy in Chronic Lymphocytic LeukemiaLeukemia & Lymphoma, 1990
- Treatment of chronic lymphocytic leukemia using chlorambucil and prednisone with or without cycle-active consolidation chemotherapy .A southeastern cancer study group trialCancer, 1986
- Treatment of chronic lymphocytic leukemia in advanced stages. A randomized trial comparing chlorambucil plus prednisone versus cyclophosphamide, vincristine, and prednisoneCancer, 1985
- Comparison of daily versus intermittent chlorambucil and prednisone therapy in the treatment of patients with chronic lymphocytic leukemiaBlood, 1977
- Bi-weekly chlorambucil treatment of chronic lymphocytic leukemiaCancer, 1974